X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (11) 11
humans (9) 9
acute myeloid leukemia (6) 6
cancer (6) 6
chemotherapy (6) 6
hematology (6) 6
aged (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
male (5) 5
multiple myeloma (5) 5
adult (4) 4
aml (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (4) 4
cytogenetics (4) 4
drug therapy (4) 4
female (4) 4
leukemia, myeloid, acute - drug therapy (4) 4
middle aged (4) 4
oncology (4) 4
transplantation (4) 4
treatment outcome (4) 4
aged, 80 and over (3) 3
bortezomib (3) 3
ixazomib (3) 3
medical research (3) 3
multiple myeloma - drug therapy (3) 3
survival (3) 3
young adult (3) 3
abridged index medicus (2) 2
adolescent (2) 2
animals (2) 2
antineoplastic combined chemotherapy protocols (2) 2
article (2) 2
azacitidine (2) 2
biopsy, needle (2) 2
bone marrow aspirate (2) 2
bone marrow trephine biopsy (2) 2
boron compounds - administration & dosage (2) 2
care and treatment (2) 2
carfilzomib (2) 2
cell biology (2) 2
cell cycle (2) 2
clinical medicine (2) 2
dexamethasone (2) 2
dexamethasone - administration & dosage (2) 2
diagnosis (2) 2
dosage and administration (2) 2
drug resistance, neoplasm (2) 2
elderly-patients (2) 2
follow-up studies (2) 2
gene expression (2) 2
glycine - administration & dosage (2) 2
glycine - analogs & derivatives (2) 2
hematology, oncology and palliative medicine (2) 2
hematopoietic stem cell transplantation (2) 2
hemic and lymphatic diseases (2) 2
induction chemotherapy (2) 2
intensive chemotherapy (2) 2
kaplan-meier estimate (2) 2
klinisk medicin (2) 2
leukemia (2) 2
leukemia, myeloid, acute - diagnosis (2) 2
leukemia, myeloid, acute - mortality (2) 2
leukemia, myeloid, acute - pathology (2) 2
low-dose cytarabine (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
minimal residual disease (2) 2
multiple myeloma - pathology (2) 2
multiple-myeloma (2) 2
neoplasms. tumors. oncology. including cancer and carcinogens (2) 2
patients (2) 2
prognosis (2) 2
recommendations (2) 2
recurrence (2) 2
retrospective studies (2) 2
risk myelodysplastic syndromes (2) 2
sensitivity and specificity (2) 2
stem cells (2) 2
thalidomide - administration & dosage (2) 2
thalidomide - analogs & derivatives (2) 2
3d culture (1) 1
achievement (1) 1
acute myeloid leukaemia (1) 1
acute myeloid-leukemia (1) 1
administration, oral (1) 1
aging (1) 1
aging - physiology (1) 1
aging rats (1) 1
agmt-study group (1) 1
aml-mrc (1) 1
analysis reveals (1) 1
angiogenesis (1) 1
angiogenesis inhibitors (1) 1
anthracyclines (1) 1
anthracyclines - administration & dosage (1) 1
anthracyclines - therapeutic use (1) 1
antimetabolites, antineoplastic (1) 1
antimetabolites, antineoplastic - therapeutic use (1) 1
antitumor-activity (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 04/2016, Volume 374, Issue 17, pp. 1621 - 1634
The addition of the oral proteasome inhibitor ixazomib to a regimen of lenalidomide plus dexamethasone led to a significant prolongation of progression-free... 
SUPERIORITY | MEDICINE, GENERAL & INTERNAL | CARFILZOMIB | RANDOMIZED PHASE-3 | THERAPY | PROTEASOME INHIBITOR MLN9708 | QUALITY-OF-LIFE | BORTEZOMIB | THALIDOMIDE | ANTITUMOR-ACTIVITY | TRANSPLANTATION | Glycine - analogs & derivatives | Glycine - adverse effects | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Boron Compounds - administration & dosage | Thalidomide - analogs & derivatives | Multiple Myeloma - drug therapy | Exanthema - chemically induced | Aged, 80 and over | Adult | Glycine - administration & dosage | Dexamethasone - administration & dosage | Double-Blind Method | Administration, Oral | Kaplan-Meier Estimate | Proportional Hazards Models | Thrombocytopenia - chemically induced | Thalidomide - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Quality of Life | Boron Compounds - adverse effects | Aged | Care and treatment | Dosage and administration | Dexamethasone | Multiple myeloma | Thrombocytopenia | Inhibitor drugs | Risk groups | Drug therapy | Peripheral neuropathy | Survival | Patients | Drug dosages | Proteasome inhibitors | Quality of life | Index Medicus | Abridged Index Medicus | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Cancer and Oncology | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5177 - 5177
Abstract INTRODUCTION: The pathogenesis of infective endocarditis (IE) , a typical biofilm-associated infectious disease frequently caused by commensal or... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4978 - 4978
Abstract BACKGROUND: Following induction chemotherapy for Acute Myeloid Leukemia (AML), patients in morphologic complete remission (mCR) with persistent... 
Journal Article
Blood, ISSN 0006-4971, 12/2015, Volume 126, Issue 23, pp. 4539 - 4539
Abstract Objectives: 1. Describe a case of severe DAT-negative intravascular hemolysis in plasma cell dyscrasia. 2. Discuss a potential novel mechanism of... 
Journal Article
Journal Article
Blood, ISSN 0006-4971, 12/2014, Volume 124, Issue 21, pp. 4185 - 4185
Abstract Background: Heparin-induced thrombocytopenia (HIT) is associated with anti-platelet factor-4 (PF4)/heparin antibodies that activate platelets,... 
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e202 - e203
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 10/2019, Volume 19, Issue 10, pp. e170 - e171
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 3_suppl, pp. 139 - 139
139 Background: High-dose chemotherapy (HDCT) and bone marrow/hematopoietic cell transplantation (BMT) is established therapy for many malignancies. While... 
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 01/2016, Volume 34, Issue 3_suppl, pp. 137 - 137
137 Background: Cancer patients (PTS) referred for autologous bone marrow transplantation (autoBMT) are frequently pre-treated with established cardiotoxins... 
Journal Article
Blood, ISSN 0006-4971, 11/2018, Volume 132, Issue Supplement 1, pp. 5643 - 5643
Abstract BACKGROUND Outcomes in multiple myeloma have improved dramatically over the last decade however, optimal sequencing of therapy remains unknown.... 
Journal Article
Blood, ISSN 0006-4971, 12/2016, Volume 128, Issue 22, pp. 2113 - 2113
Abstract Background Multiple myeloma (MM) remains incurable despite treatment advances. While passive immunotherapy such as anti-CD38 antibodies is highly... 
Journal Article
Blood, ISSN 0006-4971, 11/2019, Volume 134, Issue Supplement_1, pp. 1871 - 1871
Background: Carfilzomib is effective in the treatment of relapsed and refractory multiple myeloma (RRMM). Questions remain regarding optimal dosing strategies... 
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 06/2019, Volume 60, Issue 7, pp. 1749 - 1757
We conducted a retrospective study of 364 acute myeloid leukemia patients treated using a Day14 or a noDay14 strategy. Under the Day14 strategy, patients... 
Day14 marrow | Acute myeloid leukemia | induction chemotherapy | early reinduction | delayed reinduction | AML | DIAGNOSIS | REMISSION INDUCTION THERAPY | BIOPSY | BLAST CLEARANCE | REGIMEN | CHEMOTHERAPY | ACHIEVEMENT | ONCOLOGY | RECOMMENDATIONS | CONSOLIDATION THERAPY | HEMATOLOGY
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.